1. Home
  2. VYGR vs LWLG Comparison

VYGR vs LWLG Comparison

Compare VYGR & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • LWLG
  • Stock Information
  • Founded
  • VYGR 2013
  • LWLG 1991
  • Country
  • VYGR United States
  • LWLG United States
  • Employees
  • VYGR N/A
  • LWLG N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • LWLG Containers/Packaging
  • Sector
  • VYGR Health Care
  • LWLG Industrials
  • Exchange
  • VYGR Nasdaq
  • LWLG Nasdaq
  • Market Cap
  • VYGR 156.0M
  • LWLG 126.0M
  • IPO Year
  • VYGR 2015
  • LWLG N/A
  • Fundamental
  • Price
  • VYGR $2.97
  • LWLG $1.22
  • Analyst Decision
  • VYGR Strong Buy
  • LWLG
  • Analyst Count
  • VYGR 8
  • LWLG 0
  • Target Price
  • VYGR $14.33
  • LWLG N/A
  • AVG Volume (30 Days)
  • VYGR 841.7K
  • LWLG 1.0M
  • Earning Date
  • VYGR 08-05-2025
  • LWLG 08-08-2025
  • Dividend Yield
  • VYGR N/A
  • LWLG N/A
  • EPS Growth
  • VYGR N/A
  • LWLG N/A
  • EPS
  • VYGR N/A
  • LWLG N/A
  • Revenue
  • VYGR $66,958,000.00
  • LWLG $88,105.00
  • Revenue This Year
  • VYGR N/A
  • LWLG N/A
  • Revenue Next Year
  • VYGR $78.88
  • LWLG N/A
  • P/E Ratio
  • VYGR N/A
  • LWLG N/A
  • Revenue Growth
  • VYGR N/A
  • LWLG 24.23
  • 52 Week Low
  • VYGR $2.65
  • LWLG $0.79
  • 52 Week High
  • VYGR $9.55
  • LWLG $4.23
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 41.86
  • LWLG 54.57
  • Support Level
  • VYGR $3.24
  • LWLG $1.21
  • Resistance Level
  • VYGR $3.64
  • LWLG $1.36
  • Average True Range (ATR)
  • VYGR 0.27
  • LWLG 0.12
  • MACD
  • VYGR -0.02
  • LWLG 0.01
  • Stochastic Oscillator
  • VYGR 6.17
  • LWLG 59.18

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

Share on Social Networks: